Paige AI, Inc.
  1. Companies
  2. Paige AI, Inc.
  3. Articles
  4. An independent assessment of AI for ...

An independent assessment of AI for prostate cancer detection - Case Study

SHARE
Aug. 31, 2022
Courtesy ofPaige AI, Inc.

Yale Medicine, an academic medical center with a high volume of prostate biopsies, conducted a study to determine Paige Prostate’s utility as a prescreening tool for clinical use. A total of 1,876 prostate core biopsy slides were analyzed by Paige Prostate, and only those cores categorized by the AI as “suspicious” or as out of distribution were manually reviewed by Yale pathologists.

Most popular related searches

With assistance from AI, the study found:

  • Pathologists had to manually review only 31.4% of biopsies, signaling that Paige Prostate could substantially increase pathologist productivity in practice.
  • Paige Prostate was shown to increase detection of prostate cancer when reviewed by non-GU subspecialized pathologists.

Contact supplier

Drop file here or browse